全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Extremity Manifestations and Surgical Treatment for Nasu Hakola Disease

DOI: 10.1155/2014/458728

Full-Text   Cite this paper   Add to My Lib

Abstract:

Nasu-Hakola disease, which is also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), is a rare and mortal human genetic disorder (Verloes et al., (1997) and Bianchin et al., (2004)). Nasu-Hakola is a progressive disease characterized by early onset cognitive dementia and bone cysts (both evident by the third decade). The disease has a worldwide distribution, but most patients have been reported in Finland and in Japan (Montalbetti et al., (2004)). In the literature less than 200 cases are reported and only a few of them are about the surgical treatment for the extremity (Madry et al., (2007)). Most patients die by their fourth or fifth decade because of neurologic problems. Surgeons generally prefer conservative treatment modalities in the treatment of cystic lesions of the bone in this syndrome. In this case report, we presented a 42-year-old male with Nasu-Hakola disease having bilateral painful talar lipomembranous cystic lesions treated with curettage and iliac bone grafting. He is in the 3rd year of his followup after surgery and he has not any extremity complaints, but his neurological problems sustain. Our aim in this study is to show the beneficial aspect of surgical intervention in the cystic lesions of Nasu Hakola disease in the skeleton to obtain the patient a painless joint although surgery is rarely performed in this systemic and progressive disease. 1. Introduction Polycystic lipomembranous osteodysplasia with sclerosing Leukoencephalopathy (PLOSL), which is also named as Nasu-Hakola disease, is a rare mortal hereditary systemic disorder. The disease is characterized by progressive presenile dementia associated with multiple cyst-like bone lesions, complicated with pathologic fractures [1, 2]. Despite of the disease worldwide distribution, many cases were reported from Finland and Japan [3]. A profound dementia arises at 3rd and 4th decade and death occurs by the age 50 [1–6]. Traditionally clinical presentation of the disease contains 4 different stages: (1) latent, (2) osseous, (3) early neurological, and (4) late neurological. The symptoms begin at the osseous stage during the 3rd decade [1–6]. 2. Case Report A 42-year-old man was referred to our clinic with a history of feet pain, gait strain, and dementia for three years. The patient had progressive neurological complaints containing ataxia and amnesia. He had continuous pain in both ankles and memory disturbances. The neuroradiologic findings commonly encountered are mild to moderate cortical atrophy, bilateral calcifications in the basal

References

[1]  A. Verloes, P. Maquet, B. Sadzot, M. Vivario, A. Thiry, and G. Franck, “Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia,” Journal of Medical Genetics, vol. 34, no. 9, pp. 753–757, 1997.
[2]  M. M. Bianchin, H. M. Capella, D. L. Chaves et al., “Nasu-Hakola disease (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy—PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects,” Cellular and Molecular Neurobiology, vol. 24, no. 1, pp. 1–24, 2004.
[3]  L. Montalbetti, D. Soragna, M. T. Ratti, P. Bini, S. Buscone, and A. Moglia, “Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature,” Functional Neurology, vol. 19, no. 3, pp. 171–179, 2004.
[4]  P. Verstichel and C. Masson, “Progressive acalculia and impairment in number processing revealing a cerebral degenerative disease,” Revue Neurologique, vol. 159, no. 4, pp. 413–420, 2003.
[5]  A. Verloes, P. Maquet, B. Sadzot, M. Vivario, A. Thiry, and G. Franck, “Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia,” Journal of Medical Genetics, vol. 34, no. 9, pp. 753–757, 1997.
[6]  D. Soragna, R. Tupler, M. T. Ratti, L. Montalbetti, L. Papi, and R. Sestini, “An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene,” Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 6, pp. 825–826, 2003.
[7]  J. C. Thrash, B. E. Torbett, and M. J. Carson, Neurochemical Research, 2008.
[8]  J. Tanaka, “Nasu Hakola disease: a review of its leukoencepatic and membranolipodystrophic features,” Neuropathology, vol. 20, supplement 1, pp. 25–29, 2002.
[9]  H. Madry, J. Prudlo, A. Grgic, and J. Freyschmidt, “Nasu-Hakola disease (PLOSL): report of five cases and review of the literature,” Clinical Orthopaedics and Related Research, no. 454, pp. 262–269, 2007.
[10]  D. S. Levey, L. M. MacCormack, D. J. Sartoris, P. Haghighi, D. Resnick, and R. Thorne, “Cystic angiomatosis: case report and review of the literature,” Skeletal Radiology, vol. 25, no. 3, pp. 287–293, 1996.
[11]  L. Lateur, C. J. Simoens, S. Gryspeerdt, I. Samson, V. Mertens, and B. Van Damme, “Skeletal cystic angiomatosis,” Skeletal Radiology, vol. 25, no. 1, pp. 92–95, 1996.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133